Table: Aska Pharmaceutical Holdings - 9-MTH group results

ASKA Pharmaceutical Holdings

06/02/2023 06:00

Feb 6 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             47.26               44.18            60.00    
                 (+7.0 pct)                           (+6.0 pct)  
  Operating          5.04                4.68             5.20    
                 (+7.8 pct)                           (+8.4 pct)  
  Recurring          5.25                4.79             5.30    
                 (+9.5 pct)                           (+8.6 pct)  
  Net                4.18                4.08             4.20    
                 (+2.5 pct)                           (-2.1 pct)  
  EPS            148.19 yen          143.76 yen       148.88 yen  
  Ann Div                             15.00 yen        16.00 yen  
  -Q2 div         8.00 yen            7.00 yen                    
  -Q4 div                             8.00 yen         8.00 yen   
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T